Therapeutic Considerations for Children With Invasive Group A Streptococcal Infections: A Case Series Report and Review of the Literature

Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections . JAMA. 1993;269: 390-391 .

Barton LL , Kaplan LE Suppurative group A beta-hemolytic streptococcal infections in children . Pediatrics. 1992;89: 743-746 .

Stevens DL , Tanner MH , Winship J. , et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A . N Engl J Med. 1989;321: 1-7 .

Wheeler MC , Roe MH , Kaplan EL , Schlievert PM , Todd JK Outbreak of group A streptococcus septicemia in children; clinical, epidemiologic, and microbiological correlates . JAMA. 1991 ;266: 533-537 .

Davies HD , McGeer A. , Schwartz B. , et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group . N Engl J Med. 1996;335: 547-554 .

Laupland KB , Davies HD , Low DE , Schwartz B. , Green K. , McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group . Pediatrics. 2000;105: E60 .

Davies HD , Matlow A. , Scriver SR , et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults . Pediatr Infect Dis J. 1994;13: 49-56 .

Kotb M. Bacterial pyrogenic exotoxins as superantigens . Clin Microbiol Rev. 1995;8: 411-426 .

Schlievert PM , Assimacopoulos AP , Cleary PP Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis . J Lab Clin Med. 1996;127: 13-22 .

Norrby-Teglund A. , Norgren M, Holm SE , et al. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B . Infect Immun. 1994;62: 3731-3738 .

Norrby-Teglund A. , Basma H. , Andersson J. , McGeer A. , Low DE , Kotb M. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy . Clin Infect Dis. 1998;26: 631-638 .

Nadal D. , Lauener RP , Braegger Cp , et al. T cell activation and cytokine release in streptococcal toxic shock-like syndrome . J Pediatr. 1993;122: 727-729 .

Basma H. , Norrby-Teglund A. , Guedez Y. , et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity . Infect Immun. 1999;67: 1871-1877 .

Stevens DL , Salmi DB , McIndoo ER , Bryant AE Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among streptococcus pyogenes causing streptococcal toxic shock syndrome . J Infect Dis. 2000;182: 1117-1128 .

Auerbach SB , Schwartz B. , Williams D. , et al. Outbreak of invasive group A streptococcal infections in a nursing home; Lessons on prevention and control . Arch Intern Med. 1992;152: 1017-1022 .

Patel RA , Binns HJ , Shulman ST Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era . J Pediatr. 2004;144: 68-74 .

Waldhausen JH , Holterman MJ , Sawin RS Surgical implications of necrotizing fasciitis in children with chickenpox . J Pediatr Surg. 1996;31: 1138-1141 .

Aronoff DM , Bloch KC Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus . Medicine. 2003;82: 225-235 .

Stevens DL Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome ? Clin Infect Dis. 1995;21: 977-980 .

Schummer W. , Schummer C. Nonsteroidal anti-inflammatory drugs and streptococcal toxic shock syndrome . Intensive Care Med. 2002;28: 1194 .

Mulla ZD Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive group A streptococcal disease . Ann Epidemiol. 2003;13: 543-544 .

Martich GD , Danner RL , Ceska M. , Suffredini AF Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents . J Exp Med. 1991;173: 1021-1024 .

Spinas GA , Bloesch D. , Keller U. , Zimmerli W. , Cammisuli S. Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia . J Infect Dis. 1991;163: 89-95 .

Lesko SM , O'Brien KL , Schwartz B. , Vezina R. , Mitchell AA Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella . Pediatrics . 2001;107: 1108-15 .

Stevens DL , Gibbons AE , Bergstrom R. , Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis . J Infect Dis. 1988;158: 23-28 .

Hirata N. , Hiramatsu K. , Kishi K. , Yamasaki T. , Ichimiya T. , Nasu M. Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines . Antimicrob Agents Chemother. 2001;45: 2638-2642 .

Schlievert PM , Kelly JA Clindamycin-induced suppression of toxic-shock syndrome—associated exotoxin production . J Infect Dis. 1984;149: 471 .

Zimbelman J. , Palmer A. , Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive streptococcus pyogenes infection . Pediatr Infect Dis J. 1999;18: 1096-1100 .

Schrage B. , Duan G. , Yang L. , Fraser JD , Proft T. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome . Clin Infect Dis. 2006 ;43: 743-746 .

Norrby-Teglund A. , Kaul R. , Low DE , et al. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production . J Immunol. 1996;156: 3057-3064 .

Kaul R. , McGeer A. , Norrby-Teglund A. , et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian streptococcal study group . Clin Infect Dis. 1999;28: 800-807 .

Perez CM , Kubak BM , Cryer HG , Salehmugodam S. , Vespa P. , Farmer D. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review . Am J Med. 1997;102: 111-113 .

Norrby-Teglund A. , Kaul R. , Low DE , et al. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G . Infect Immun. 1996;64: 5395-5398 .

Darenberg J. , Ihendyane N. , Sjolin J. , et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock

syndrome: a European randomized, double-blind, placebo-controlled trial . Clin Infect Dis. 2003;37: 333-340 .

Barry W. , Hudgins L. , Donta ST , Pesanti EL Intravenous immunoglobulin therapy for toxic shock syndrome . JAMA. 1992;267: 3315-3316 .

Laupland KB , Boucher P. , Rotstein C. , Cook DJ , Doig CJ Intravenous immunoglobulin for severe infections: A survey of Canadian specialists . J Crit Care. 2004;19: 75-81 .